Search

You searched for "ESCRS"

361 results found

AI predicts eye damage from autoimmune drug, years before symptoms appear

1 September 2025 | artificial intelligence, hydroxychloroquine, pharmacology, research, Moorfields
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...

Long way up

3 February 2023 | | EYE - Cataract, EYE - Glaucoma, EYE - Cornea, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
In the first of a series of guest editorials exploring multiple different Learning Curves, Francis Sanders ruminates on motorcycling and environmental guilt. As an avid motorcyclist, I was naturally drawn to the relatively recent sequel series from Ewan McGregor and...

Haag-Streit Academy to host an ‘iTrack Advance Masterclass’

20 April 2023 | Company Profiles, Research & Development
Haag-Streit UK is delighted to confirm the launch of the iTrack Advance Masterclass. This will take place at Vision Engineering Headquarters, Woking on Friday 28th July 2023.

Biotech Healthcare Successfully Concludes Global Phakic Users Meeting 2024 in Barcelona

14 October 2024 | Company Profiles, Awards, Conferences & Anniversaries
October 3, 2024 – Celebrating its 25th anniversary, Biotech Healthcare hosted the Global Phakic Users Meeting 2024 at the stunning Joan Miró Foundation in Barcelona on 5th September. Bringing together over 150 ophthalmologists from 28 countries, the event showcased Biotech's...

Haag-Streit Academy prepares for final slit lamp courses & Skills Hub of the year

4 August 2025 | Company Profiles, Research & Development
Haag-Streit Academy has become renowned for its exceptional slit lamp courses, aimed at clinicians with a variety of slit lamp skills, whether they are complete beginners, or more advanced users of the equipment. Additionally, Haag-Streit Academy offers a Slit Lamp...

RNIB working with games studios to make VR more accessible

11 December 2025 | technology, charity, services
Abertay University and RNIB launch toolkit to make extended reality experiences more accessible for blind and partially sighted people. The new guidance launched in December 2025 will support accessible design in games and immersive experiences for blind and partially sighted...

All-star cast brings Pride and Prejudice to life for milestone Talking Books anniversary

23 February 2026 | news, charity, culture section
Leading sight loss charity, the Royal National Institute of Blind People (RNIB) is celebrating 90 years of its renowned Talking Books Service with a retelling of Jane Austen’s classic love story, Pride and Prejudice. Twelve of the UK’s best-loved actors...

College of Optometrists publishes guidance on GLP-1 weight loss drugs and vision

1 April 2026 | treatment, optometry, public health
GLP-1 weight loss drugs and vision: what clinicians need to know The College of Optometrists has issued guidance for clinicians following the publication of a recent MHRA drug safety update which has drawn attention to a very rare risk of...

UK Eye Care Data Hub updated with additional eye conditions

28 April 2026 | optometry, research
The UK Eye Care Data Hub, the most up-to-date and comprehensive model of the UK’s eyecare workforce and eye diseases in one place, has been expanded to almost double the number of eye conditions and update aspects of the sector...

Just sign here: the intricacies of consent in the post-Montgomery era

1 February 2018 | EYE - General
The consent process is a vital part of the patient pathway and is far more than just getting the patient to sign on the dotted line. In my work in litigation I often see issues around informed consent resulting in...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...

Blind Faith: In Conversation with Mariya Moosajee

16 August 2023 | EYE - General
In light of the BBC releasing Blind Faith: Do genetic eye disease ‘treatments' work? earlier this year, a documentary which follows BBC journalist Ramadan Younes as he investigates practitioners who falsely claim to have ‘treatments’ for genetic eye disease, Eye...